27W-43003-99254
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 857 / AZ
- Registered
- 2021-08-19
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-19
Registered in v-safe
-
2021-08-19
Dose 1 — Pfizer-BioNTech
- 2021-08-19
- 2021-08-20
-
2021-08-21
Survey response — days 1–6 daily, dose 1MedDRA: Exposure to SARS-CoV-2 — Feeling: FairFree text: Exposed to covid 19 positive colleague todayMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-24
- 2021-08-25
-
2021-09-09
Dose 2 — Pfizer-BioNTech
-
2021-09-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-19 | Pfizer-BioNTech | No |
| 2 | 2021-09-09 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Exposed to covid 19 positive colleague today
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Exposure to SARS-CoV-2 | ✓ | · | ✓ |
| SRO | Rhinorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release